Human papillomavirus in HIV associated lung cancers
HIV相关肺癌中的人乳头瘤病毒
基本信息
- 批准号:10361530
- 负责人:
- 金额:$ 35.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS related cancerAcquired Immunodeficiency SyndromeAffectAttenuatedBiological ModelsCancer EtiologyCancer PatientCancer cell lineCause of DeathCell Culture TechniquesCellsCessation of lifeClinicalData SetDevelopmentDiseaseDisease ManagementEpithelial CellsEstrogen AntagonistsEstrogen Receptor alphaEstrogensEtiologyExhibitsFeedbackFutureGene ExpressionGeneral PopulationGenetic TranscriptionGenomicsGoalsGrowthHIVHPV-High RiskHighly Active Antiretroviral TherapyHuman CloningHuman Papilloma Virus VaccinationHuman PapillomavirusHuman papilloma virus infectionHuman papillomavirus 16Immune EvasionIncidenceIndividualInformaticsKaposi SarcomaLungMalignant NeoplasmsMalignant neoplasm of cervix uteriMalignant neoplasm of lungMediatingMethodsMicrobeMonitorNon-Hodgkin&aposs LymphomaOncogenesOncogenicOncoproteinsPatient CarePatientsPersonsPhenotypePopulationRegimenResearchRisk FactorsRoleSamplingSensitivity and SpecificitySignal TransductionSmokingSmoking StatusTechnologyTestingTherapeuticTimeTranscriptViralViral OncogeneVirus IntegrationWorkbasecancer riskcircular RNAgene producthuman papilloma virus oncogeneimprovedknock-downlung cancer celllung carcinogenesismalignant phenotypenext generation sequencingnovelpathogenpersonalized medicinepreventsextranscriptometranscriptome sequencingtumortumor-immune system interactionstumorigenesis
项目摘要
SUMMARY
In recent years, the incidence of AIDS-defining cancers has dramatically decreased due to the HAART therapy.
In contrast, the incidence of the non-AIDS-defining cancers (NADC), especially lung cancer (LC) has risen by
more than 3 fold. In the U.S., LC has become the most common NADC with an incidence rate of 204 cases per
100,000 person-years. LC is also the most common NADC cause of death and accounts for 21% of cancer-
related death in the HIV(+) population. Although smoking is a key risk factor for HIV associated LCs, HIV(+)
individuals still have a 3-fold increased LC risk after controlling for smoking status, indicating that other factors
are responsible for this increased incidence. Unlike other common HIV associated cancers such as cervical
cancer, non-Hodgkin's lymphoma, and Kaposi's sarcoma, HIV associated LCs do not have a known viral
etiology. To discover any potential oncopathogen for HIV associated LCs, we have utilized our Next-
Generation-Sequencing-based PARSES pipeline to interrogate more than 1,000 LC RNA-seq data sets. We
discovered that human papillomavirus (HPV) is causally associated with LCs in the HIV(+) population. The
overarching goal of this proposal is to determine the involvement of HPV in HIV associated LCs using our well-
established sequencing based informatics approaches as well as newly created HPV(+) HIV associated LC
model systems. We will first examine the hypothesis that there is a causal association between HPV and LCs
in the HIV(+) population but not in the general population. In addition, we will test the hypothesis that HPV
promotes lung oncogenesis by enhancing the estrogen-mediated growth signaling and expressing viral
E5/E6/E7/hpv-circ-880-408 oncogenes in the HIV(+) individuals. We will elucidate the critical roles of HPV
oncogene products including a novel viral circular RNA and estrogen-mediated growth signaling and immune-
evasion in HIV associated lung carcinogenesis. We will simultaneously examine an important concept of being
able to precisely treat HPV(+) HIV associated LCs with anti-estrogen and/or anti-HPV regimens in the era of
personalized medicine. Further, by determining the HPV etiology, our work may help prevent LCs by promoting
HPV vaccination for both sexes. Together, completion of the research will add conceptually to our
understanding of HIV associated LCs and provide potentially unique therapeutic opportunities and ultimately
benefit a subset of HIV(+) LC patients.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhen Lin其他文献
Zhen Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhen Lin', 18)}}的其他基金
Vitamin D in viral associated lung cancers
维生素 D 在病毒相关肺癌中的作用
- 批准号:
10604870 - 财政年份:2022
- 资助金额:
$ 35.24万 - 项目类别:
Human papillomavirus in HIV associated lung cancers
HIV相关肺癌中的人乳头瘤病毒
- 批准号:
10577760 - 财政年份:2021
- 资助金额:
$ 35.24万 - 项目类别:
Human papillomavirus in HIV associated lung cancers
HIV相关肺癌中的人乳头瘤病毒
- 批准号:
10253590 - 财政年份:2021
- 资助金额:
$ 35.24万 - 项目类别:
Project 3-Human papillomavirus in HIV associated lung cancers
项目3-人类乳头瘤病毒在HIV相关肺癌中的作用
- 批准号:
10223350 - 财政年份:2020
- 资助金额:
$ 35.24万 - 项目类别:
Protecting Genetic Privacy through Risk Assessment
通过风险评估保护基因隐私
- 批准号:
7076320 - 财政年份:2006
- 资助金额:
$ 35.24万 - 项目类别:
Protecting Genetic Privacy through Risk Assessment
通过风险评估保护基因隐私
- 批准号:
7492263 - 财政年份:2006
- 资助金额:
$ 35.24万 - 项目类别:
Protecting Genetic Privacy through Risk Assessment
通过风险评估保护基因隐私
- 批准号:
7287366 - 财政年份:2006
- 资助金额:
$ 35.24万 - 项目类别:
Project 3-Human papillomavirus in HIV associated lung cancers
项目3-人类乳头瘤病毒在HIV相关肺癌中的作用
- 批准号:
9545029 - 财政年份:
- 资助金额:
$ 35.24万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 35.24万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 35.24万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 35.24万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 35.24万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 35.24万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 35.24万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 35.24万 - 项目类别: